STATegics, Inc. Announces a New Grant from Friedreich’s Ataxia Research Alliance

STATegics, Inc. Announces a New Grant from Friedreich’s Ataxia Research Alliance. PRLog (Press Release) - Jan. 8, 2013 - Menlo Park, California.

STATegics, Inc. awarded a new grant from the Friedreich’s Ataxia Research Alliance (FARA) to advance erythropoietin receptor agonist compounds for the treatment of Friedreich’s ataxia (FRDA).